PMID- 23429583 OWN - NLM STAT- MEDLINE DCOM- 20130705 LR - 20220331 IS - 1522-1547 (Electronic) IS - 0193-1857 (Print) IS - 0193-1857 (Linking) VI - 304 IP - 9 DP - 2013 May 1 TI - BMP2 inhibits TGF-beta-induced pancreatic stellate cell activation and extracellular matrix formation. PG - G804-13 LID - 10.1152/ajpgi.00306.2012 [doi] AB - Activation of pancreatic stellate cells (PSCs) by transforming growth factor (TGF)-beta is the key step in the development of pancreatic fibrosis, a common pathological feature of chronic pancreatitis (CP). Bone morphogenetic proteins (BMPs), members of the TGF-beta superfamily, have anti-fibrogenic functions, in contrast to TGF-beta, in the kidney, lung, and liver. However, it is not known whether BMPs have an anti-fibrogenic role in the pancreas. The current study was designed to investigate the potential anti-fibrogenic role of BMPs in the pancreas using an in vivo CP model and an in vitro PSC model. CP was induced by repetitive intraperitoneal injections of cerulein in adult Swiss Webster mice. The control mice received saline injections. Compared with the control, cerulein injections induced a time-dependent increase in acinar injury and progression of fibrosis and a steady increase in inflammation. Cerulein injections also induced increases of the extracellular matrix (ECM) protein fibronectin and of alpha-smooth muscle actin (alpha-SMA)-positive stellate cells (PSCs). The mice receiving cerulein injections showed increased BMP2 protein levels and phosphorylated Smad1 levels up to 4 wk and then declined at 8 wk to similar levels as the control. In vitro, the isolated mouse and human PSCs were cultured and pretreated with BMP2 followed by TGF-beta treatment. BMP2 pretreatment inhibited TGF-beta-induced alpha-SMA, fibronectin, and collagen type Ia expression. Knocking down Smad1 with small-interfering RNA reversed the inhibitory effect of BMP2 on TGF-beta-induced alpha-SMA and fibronectin expression. Thus, BMP2 opposes the fibrogenic function of TGF-beta in PSCs through the Smad1 signaling pathway. FAU - Gao, Xuxia AU - Gao X AD - Department of Surgery, University of Texas Health Science Center-Houston, Houston, TX 77026, USA. FAU - Cao, Yanna AU - Cao Y FAU - Yang, Wenli AU - Yang W FAU - Duan, Chaojun AU - Duan C FAU - Aronson, Judith F AU - Aronson JF FAU - Rastellini, Cristiana AU - Rastellini C FAU - Chao, Celia AU - Chao C FAU - Hellmich, Mark R AU - Hellmich MR FAU - Ko, Tien C AU - Ko TC LA - eng GR - P01-DK-035608/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20130221 PL - United States TA - Am J Physiol Gastrointest Liver Physiol JT - American journal of physiology. Gastrointestinal and liver physiology JID - 100901227 RN - 0 (Actins) RN - 0 (Bone Morphogenetic Protein 2) RN - 0 (Fibronectins) RN - 0 (Smad1 Protein) RN - 0 (Smad1 protein, mouse) RN - 0 (Transforming Growth Factor beta) RN - 888Y08971B (Ceruletide) SB - IM MH - Actins/metabolism MH - Animals MH - Bone Morphogenetic Protein 2/*pharmacology MH - Ceruletide/pharmacology MH - Extracellular Matrix/metabolism MH - Female MH - Fibronectins/biosynthesis MH - Fibrosis MH - Humans MH - Mice MH - Pancreas/pathology MH - Pancreatic Stellate Cells/*drug effects MH - Pancreatitis, Chronic/chemically induced/pathology MH - Signal Transduction MH - Smad1 Protein/physiology MH - Transforming Growth Factor beta/antagonists & inhibitors/*pharmacology PMC - PMC3652003 OTO - NOTNLM OT - bone morphogenetic protein OT - pancreas stellate cell OT - pancreatic fibrosis OT - transforming growth factor-beta EDAT- 2013/02/23 06:00 MHDA- 2013/07/06 06:00 PMCR- 2014/05/01 CRDT- 2013/02/23 06:00 PHST- 2013/02/23 06:00 [entrez] PHST- 2013/02/23 06:00 [pubmed] PHST- 2013/07/06 06:00 [medline] PHST- 2014/05/01 00:00 [pmc-release] AID - ajpgi.00306.2012 [pii] AID - GI-00306-2012 [pii] AID - 10.1152/ajpgi.00306.2012 [doi] PST - ppublish SO - Am J Physiol Gastrointest Liver Physiol. 2013 May 1;304(9):G804-13. doi: 10.1152/ajpgi.00306.2012. Epub 2013 Feb 21.